Stealth BioTherapeutics Corp. Sponsored ADR Debt to Equity Ratio 2019-2022 | MITO
Current and historical debt to equity ratio values for Stealth BioTherapeutics Corp. Sponsored ADR (MITO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Stealth BioTherapeutics Corp. Sponsored ADR debt/equity for the three months ending March 31, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-03-31 |
$0.09B |
$-0.05B |
-1.71 |
2021-12-31 |
$0.10B |
$-0.05B |
-2.11 |
2021-09-30 |
$0.07B |
$-0.03B |
-2.53 |
2021-06-30 |
$0.06B |
$-0.03B |
-2.23 |
2021-03-31 |
$0.05B |
$-0.01B |
-3.88 |
2020-12-31 |
$0.05B |
$-0.01B |
-4.46 |
2020-09-30 |
$0.02B |
$0.00B |
8.91 |
2020-06-30 |
$0.02B |
$0.01B |
1.91 |
2020-03-31 |
$0.03B |
$0.00B |
12.25 |
2019-12-31 |
$0.04B |
$0.02B |
2.06 |
2019-09-30 |
$0.04B |
$0.00B |
9.71 |
2019-06-30 |
$0.04B |
$0.02B |
1.87 |
2019-03-31 |
$0.04B |
$0.03B |
1.15 |
2018-12-31 |
$0.19B |
$-0.18B |
-1.09 |
2018-09-30 |
$0.00B |
|
0.00 |
2018-06-30 |
$0.00B |
|
0.00 |
2018-03-31 |
$0.00B |
|
0.00 |